Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Gross-Profit" stands at 1.51 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.
Daiichi Sankyo Co. Ltd.'s first quarter result of 0.3823 Trillion JPY for the item "Gross Profit" represents a decrease of -9.92 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Daiichi Sankyo Co. Ltd.'s first quarter result of 0.3823 Trillion JPY for the item "Gross Profit" represents an increase of 12.06 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Daiichi Sankyo Co. Ltd.'s first quarter result of 1.51 Trillion JPY for the item "Gross Profit" represents an increase of 2.80 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 18.99 percent compared to the value the year prior.
The 1 year change in percent is 18.99.
The 3 year change in percent is 110.48.
The 5 year change in percent is 139.18.
The 10 year change in percent is 155.26.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Gross Profit | 905,699,262,464.00 |
![]() | Johnson & Johnson - Gross Profit | 486,508,953,600.00 |
![]() | AbbVie Inc - Gross Profit | 399,570,305,024.00 |
![]() | Roche Holding AG - Gross Profit | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Gross Profit | 280,205,508,085.11 |